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Abstract 
Some biomaterials are osteoinductive, i.e., they are able to trigger the osteogenic process by 
inducing the differentiation of mesenchymal stem cells to the osteogenic lineage. Although the 
underlying mechanism is still unclear, microporosity and specific surface area (SSA) have been 
identified as critical factors in the material-associated osteoinduction. However, only sintered 
ceramics, with a limited range of porosities and SSA, have been analysed so far. In this work we 
were able to extend this range to the nanoscale, through the foaming and 3D-printing of biomimetic 
calcium phosphates, obtaining scaffolds with controlled micro and nanoporosity together with a 
tailored macropore architecture. Calcium deficient hydroxyapatite (CDHA) scaffolds were evaluated 
after 6 and 12 weeks in an ectopic implantation canine model, and compared with two sintered 
ceramics, biphasic calcium phosphate and beta-tricalcium phosphate. Only foams with spherical 
concave macropores, and not 3D-printed scaffolds with convex prismatic macropores induced 
significant ectopic bone formation. Amongst them, biomimetic nanostructured CDHA produced the 
highest incidence of ectopic bone and accelerated bone formation when compared to conventional 
microstructured sintered calcium phosphates with the same macropore architecture. Moreover, 
they exhibited different bone formation patterns, since in CDHA foams the new ectopic bone 
progressively replaced the scaffold, whereas in sintered biphasic calcium phosphate scaffolds bone 
was deposited on the surface of the material, progressively filling the pore space. In conclusion, this 
study demonstrates that the high reactivity of nanostructured biomimetic CDHA, combined with a 
spherical concave macroporosity allows pushing the osteoinduction potential beyond the limits of 
microstructured calcium phosphate ceramics. 
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1. Introduction 
Some biomaterials are able to instruct cells and, by driving cell fate, they are able to modulate the 
regenerative potential of specific tissues. A good example is what has been called material-
associated osteoinduction, i.e., the capacity of some biomaterials to induce the differentiation of 
mesenchymal stem cells into the osteoblastic lineage, even in absence of exogenously applied 
bone morphogenetic proteins (BMPs). This property, that was discovered in the early 1990’s for 
calcium phosphates (CaP)1,2 is of paramount importance when designing synthetic bone grafts. 
Intrinsic osteoinduction can endorse the biomaterial with the capacity to regenerate bone even in 
compromised clinical situations, avoiding the detrimental side effects associated to the use of 
BMPs3,4. The relevance of this topic is linked to the high incidence of bone grafting procedures, 
around 2.2 million worldwide annually5. In this context, the development of synthetic bone 
substitutes with enhanced performance, able to outperform autologous bone grafts and to avoid 
their intrinsic drawbacks, e.g. limited availability, donor site pain and risk of infection or disease 
transmission6, is an urgent challenge. 
Great attention has been paid in the last years to the parameters leading to biomaterial-associated 
osteoinduction. Some CaP ceramics have been found to exhibit an intrinsic osteoinductive capacity 
when implanted ectopically in several animal models7, which is associated to a higher bone healing 
capacity when implanted orthotopically, compared to non-osteoinductive ceramics8. It has also 
been reported that osteoinductive ceramics perform similarly to both autologous bone graft and 
rhBMP2-impregnated collagen sponge in repairing critical-size bone defects9. Although the 
mechanism underlying bone induction is still not fully understood, the textural properties of the 
material are believed to play a key role10-13. However, most studies on osteoinduction of CaP have 
been performed with sintered ceramics, where the high temperature processing precludes the 
introduction of nanoporosity. Consequently, low specific surface areas (SSA) are obtained, 
normally in the range of 0.2-2 m2/g. This leaves the hypothesis without a complete verification, and 
establishes the need to provide a full picture of the situation, by assessing the osteoinductive 
properties of CaP biomaterials with nanostructured features and higher SSA.  
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The recent biomimetic routes based on the self-setting reaction of calcium phosphate cements 
(CPCs) have opened up new possibilities in this respect, since they allow obtaining nanostructured 
CaP scaffolds, with controlled micro and nanoporosity, together with a tailored architecture14. As a 
result of the setting reaction, an entangled network of hydroxyapatite nanocrystals is obtained at 
physiological temperature, which does not simply mimic the composition and morphology of the 
bone mineral phase better than sintered CaP biomaterials, but also generate a porous structure 
with specific nano/micro porosities, and consequently, much higher SSA than sintered ceramics. 
One additional advantage of CPCs is their simplicity in processing, which makes them extremely 
versatile and compatible with many techniques. Nanostructured hydroxyapatite foams, with open 
interconnected macropores can be obtained by adding small amounts of a surfactant in the liquid 
phase of the CPC and applying mechanical stirring15,16. Moreover, biomimetic processing of 
hydroxyapatite is compatible with additive manufacturing strategies. Self-setting calcium phosphate 
inks have been designed17 that allow the fabrication of nanostructured hydroxyapatite scaffolds with 
controlled pore architecture, using 3D-microextrusion techniques, also known as robocasting18. 
Taking advantage of these technologies, scaffolds with diverse pore architectures can be obtained, 
while preserving the specific textural properties typical of biomimetic ceramics. The possibility to 
tailor porosity at different levels, from the nano- to the macroscale, significantly extends the range 
of textures analyzed so far and allows addressing more in-depth the effect of the nanostructure on 
the osteoinductive properties of calcium phosphates. The aim of this study was to assess the 
relative importance of nanostructural features and scaffold architecture to the osteoinduction of 
calcium phosphate biomaterials in a canine ectopic model. Biomimetic calcium deficient 
hydroxyapatite (CDHA) scaffolds with different pore architectures were compared to two sintered 
CaP ceramics, i.e. a biphasic calcium phosphate (BCP) and beta-tricalcium phosphate (β-TCP). 
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2. Materials and Methods 
2.1. Calcium phosphate materials 
2.1.1. Synthesis of alpha-tricalcium phosphate  
Alpha-tricalcium phosphate (α-Ca3(PO4)2, α-TCP) was the solid phase of the cement used for the 
fabrication of the scaffolds. Briefly, α-TCP was obtained by heating calcium hydrogen phosphate 
(CaHPO4, Sigma-Aldrich, St. Louis, USA) and calcium carbonate (CaCO3, Sigma-Aldrich, St. Louis, 
USA) at a 2:1 molar ratio for 15h at 1400°C followed by quenching in air. Subsequently, the powder 
was milled in an agate ball mill (Pulverisette 6, Fritsch GmbB, Markt Einersheim, Germany), with 10 
balls (d = 30 mm) for 60 min at 450 rpm followed by a second milling for 40 min at 500 rpm with 10 
balls (d = 30 mm) and a third one for 60 min at 500 rpm with 100 balls (d = 10 mm), to attain a 
mean powder particle size of 2.8µm. 
 
2.1.2. Preparation of foamed scaffolds 
To obtain the CDHA foams (CDHA-Foam) a solid phase consisting of 98 wt% α-TCP and 2 wt% of 
precipitated hydroxyapatite (PHA, Merck KGaA, Darmstadt, Germany) was mixed with an aqueous 
solution of 1 wt% Polysorbate 80 (Tween 80®, Sigma-Aldrich, St. Louis, USA) at a liquid to powder 
ratio of 0.65 mL/g. The mixture was foamed with a domestic food mixer for 30s at 7000 rpm and 
then transferred to Teflon cylindrical moulds (5 mm diameter and 10 mm height). After keeping the 
samples in 100% relative humidity for 8 h to ensure cohesion, they were immersed in deionized 
water at 37°C for 10 days, to allow for the hydrolysis reaction of α-TCP to CDHA to take place, 
according to the following reaction (Eq.1): 
 
3 Ca3(PO4)2 + H2O → Ca9(PO4)5(HPO4)OH    (Eq. 1) 
 
To obtain the biphasic hydroxyapatite/β-TCP foams (BCP-Foam), instead of immersing the foams 
in water at 37ºC, they were unmoulded, immersed in a 1 wt% sodium bicarbonate solution 
(NaHCO3, Sigma-Aldrich, St. Louis, USA) and autoclaved at 120ºC and 1 atm for 30min. 
Subsequently, they were sintered at 1100°C for 9h to obtain a BCP with a 80:20 HA:β-TCP ratio. 
Additional information on this protocol is provided in the Supplementary Data (Fig. S1). The β-TCP 
foams (β-TCP-Foam) were obtained by sintering the CDHA foams at 1100°C for 9 h. 
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For the in vitro studies, 5 mm diameter x 0.3 mm height discs of CDHA (CDHA-disc), β-TCP (β-
TCP-disc) and BCP (BCP-disc) were prepared, following the procedures described above for the 
foamed scaffolds, except for the foaming step, which was substituted by a mortar mixing for 1min. 
 
2.1.3. Preparation of robocast scaffolds 
To prepare the CDHA self-setting ink, a 30 wt% aqueous solution of poloxamer 407 (P2443 - 
Pluronic® F-127, Sigma-Aldrich, St. Louis, USA) was mixed with the α-TCP powder at a liquid to 
powder ratio of 0.65 g/g. A cylindrical CAD model of the scaffolds (5 mm diameter and 10 mm 
height) was designed (Solidworks 2014, Dassault Systèmes SolidWorks Corp., Waltham, USA) and 
converted to a .STL 3D mesh, with a rectilinear pattern and an infill of 0.45. Two different nozzles 
were used, with an inner diameter of 450 or 250 μm for the CDHA-Rob-450 and CDHA-Rob-250 
respectively. To print the scaffolds, the self-setting ink was introduced immediately after mixing into 
the cartridge of the robocasting device (Pastecaster, BCN3D Technologies, Barcelona, Spain). The 
scaffolds were left overnight in an incubator in100% relative humidity at 37ºC, and subsequently 
immersed in deionized water at 37ºC for a 10 days hardening period.  
 
2.1.4. Materials characterization 
The scaffolds were characterized in terms of phase composition, microstructure, specific surface 
area and porosity. Phase characterization was performed by X-ray diffraction using a diffractometer 
(D8 Advance, Bruker Corp., Billerica, USA) equipped with a Cu Kα anode operated at 40 kV and 40 
mA. Data were collected in 0.02° steps over the 2θ range of 10°-80° with a counting time of 2s per 
step. Phase identification was accomplished comparing the experimental patterns to those of 
hydroxyapatite (JCPDS 09-0432), α-TCP (JCPDS 09-0348) and β-TCP (JCPDS 09-0169). 
Quantitative phase composition analyses were carried out using DIFFRAC.EVA software, (Bruker 
Corp., Billerica, USA). The morphology of the scaffolds was assessed by micro-computed 
tomography (micro-CT, SkyScan 1172, Bruker microCT, Kontich, Belgium) at a voltage of 90 kV 
and current of 112 µA, with a Cu-Al filter. Images were acquired using an isotropic pixel size of 5 
µm. Reconstruction of cross-sections was done using software package NRecon (Bruker microCT, 
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Kontich, Belgium). Calculations of macroporosity were performed with CTAn (Bruker microCT, 
Kontich, Belgium). The microstructure was characterized by scanning electron microscopy (Zeiss 
Neon40 EsBCrossBeam, Zeiss, Oberkochen, Germany). Prior to imaging, samples were coated 
with carbon to enhance conductivity. The SSA was determined by nitrogen adsorption using the 
BET (Brunauer-Emmett-Teller) method (ASAP 2020, Micrometrics Instrument Corp., Norcross, 
USA). Porosity and pore entrance size distribution were measured by mercury intrusion 
porosimetry (MIP, AutoPore IV, Micrometrics Instrument Corp., Norcross, USA). All samples were 
dried at 100°C for 2 h prior to measurement.  
 
2.2. In vivo study 
2.2.1. Animal model and intramuscular implantation 
The capacity of the scaffolds to form ectopic bone was evaluated in a standardized intramuscular 
implantation model in canine. 12 adult beagle dogs (body weight 14-17 kg) were purchased from a 
professional stock breeder (Isoquimen S.L., Barcelona, Spain). All animal procedures were in 
compliance with the Guide for Care and Use of Laboratory Animals19 and the European Community 
Guidelines (Directive 2010/63/EU) for the protection of animals used for scientific purposes20. 
Ethical approval for the procedures was obtained from the local ethic committee (CEAAH 2338). On 
reception, animals were randomly divided into 2 groups of 6 dogs each, corresponding to two 
different sacrificial times (6 weeks/12 weeks). Afterwards, the animals were acclimatized to their 
local environment for 2 weeks prior to surgery.  
For the surgical procedure, dogs were preanesthetized using an intramuscular injection of 
medetomidine and methadone. Anesthesia was induced by intravenous injection of propofol and 
diazepam and maintained with inhaled isoflorane in an oxygen carrier. During surgery the animals 
received an intravenous saline isotonic solution and intravenous injection of cefazolin. For the 
intramuscular implantation animals were placed in sternal recumbency and the lumbar areas were 
shaved and scrubbed with chlorhexidine gluconate solution for an aseptic preparation of the 
surgical field. Subsequently, one skin incision was performed on the lumbar region and fascia 
incisions were created in the paraspinal muscles bilaterally by scalpel. Using blunt dissection 
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intramuscular pockets were created with a cranio-caudal direction and 4 cm lateral to the spinal 
axis. Each intramuscular pocket was filled with one of the above-mentioned cylindrical scaffolds (ø 
5 mm x 10 mm of height): CDHA-Foam, CDHA-Rob-450, CDHA-Rob 250, BCP-Foam, B-TCP-
Foam, applying a rotatory allocation system and a block design. Therefore, one construct of each 
material was implanted in each dog resulting in 5 scaffolds implanted per animal, leaving a distance 
of 5 cm between implants. All scaffolds had been previously sterilized by Gamma irradiation at a 
dose of 25 kG. Table 1 shows the list of implanted materials. Finally, muscular fasciae were closed 
with monofilament synthetic non-resorbable sutures for identification at harvest and subcutaneous 
tissue and skin incisions were closed layer by layer with monofilament synthetic absorbable 
sutures. Immediately after surgery, the animals received subcutaneously a prophylactic long-acting 
antibiotic (cefovecin) and pain relief (methadone and meloxicam).  
 
Table 1. Summary of implanted samples                                                
   Intramuscular implantation 
Architecture Composition Codes 6 weeks 12 weeks 
Foams 
Calcium deficient hydroxyapatite CDHA-Foam 6 6 
80:20 hydroxyapatite:β-TCP BCP-Foam 6 6 
β-TCP β-TCP-Foam 6 6 
Robocast 
Calcium deficient hydroxyapatite CDHA-Rob-450 6 6 
Calcium deficient hydroxyapatite CDHA-Rob-250 6 6 
 
During the postoperative period, a non-steroidal anti-inflammatory drug was given subcutaneously 
to the animals for 7 days to prevent pain and inflammation. The animals were euthanized at 6 and 
12 weeks post-implantation, by an intravenous injection of an overdose of pentobarbital sodium. A 
pre-euthanasia sedation of medetomidine was used for animal welfare reasons. 
 
2.2.2. Sample harvest and histological processing 
Immediately after euthanasia, the samples were harvested with their surrounding muscular tissue 
and fixed in 4% neutral buffered formalin solution for 72 hours. After fixation, they were dehydrated 
in an increasing series of ethanol solutions and embedded in four different graded mixtures of 
ethanol and methylmethacrylate resin (Technovit 7200, HeraeusKulzer GmbH, Hanau, Germany) 
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under vacuum conditions. The specimens were subsequently photopolymerized with 2 h of white 
light and 4 h of ultraviolet light, obtaining blocks that were scanned by X-ray micro-CT. After micro-
CT scanning, each block was divided transversally, perpendicular to the long axis of the implant, 
into two equal pieces. One piece was sectioned and polished (EXAKT Cutting & Grinding System, 
EXAKT Advanced Technologies GmbH, Norderstedt, Germany) prior to sputtering of the surface 
with carbon to enhance conductivity for backscattered scanning electron microscopy analysis (BS-
SEM). The other piece was sliced into 500 μm thick sections, followed by a subsequent thinning to 
50 μm by grinding (Cutting & Grinding System, EXAKT Advanced Technologies GmbH, 
Norderstedt, Germany). The sections were then stained with Goldner-Masson trichrome and 
Toluidine blue for histological observation under light microscopy.  
 
2.2.3. Histology and histomorphometry 
The micro-CT analysis (SkyScan 1172, Bruker microCT, Kontich, Belgium) of the tissue samples 
was performed using the same settings as for the scaffolds scanning described above. The 3D 
quantification of new bone formation and scaffold degradation was performed following a previously 
established protocol21, where the BS-SEM images were used as a reference to determine the grey 
scale intensity thresholds to differentiate bone and calcium phosphate biomaterial in the micro-CT 
images. The following parameters were quantified: 
a) Percentage of newly formed bone within the available macropore space: 
% newly formed bone = (bone volume / available macropore volume) * 100 
b) Percentage of scaffold degradation, calculated by subtracting the remaining scaffold volume 
from the initial scaffold volume prior to implantation: 
% scaffold degradation = [(initial scaffold volume – final scaffold volume) / initial scaffold volume)] * 100 
Moreover, the radius of each implanted scaffold was divided into five equal segments to define five 
concentric volumes of interest (VOIs). The percentage of newly formed bone was calculated in 
each VOI, to assess the distribution of the new ectopic bone formation. 
The BS-SEM observations (Zeiss Neon40 EsBCrossBeam, Zeiss, Oberkochen, Germany) were 
made at 20 kV to assess the presence, localization and maturity of the newly formed bone tissue 
and scaffold degradation based on its morphology and the different contrast levels. The number of 
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samples that showed any bone formation per the total number of samples implanted (bone 
incidence rate) was recorded. 
Stained histological sections were scanned using a light microscope (Nikon Eclipse E800, Nikon 
Corp.,Tokyo, Japan) fitted with a digital camera (ProgRes, Jenoptik AG, Jena, Germany) for a 
qualitative evaluation focused on fibrous tissue infiltration, presence of bone cells (osteoblasts, 
osteocytes and osteoclasts), grade of neovascularization and grade of peri-implant inflammatory 
reaction. Digital images were captured using an image analysis software (ProgRes CapturePro, 
Jenoptik AG, Jena, Germany). 
 
2.3. In vitro study 
2.3.1. Cell culture 
To better understand the mechanisms leading to osteoinduction, rat mesenchymal stem cells 
(rMSCs) were cultured in direct contact with the different materials used in the in vivo study. rMSCs 
were isolated from tibias and femurs of Lewis rats and characterized by flow cytometry as 
described elsewhere22. Cells were expanded in Advanced Dulbecco's Modified Eagle Medium 
(AdvDMEM) supplemented with 10% fetal bovine serum (FBS), 20 mM4-(2-
Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) buffer, 2 mM L-glutamine (50 U/ml) and 
penicillin/streptomycin (50 µg/ml), all from Thermo Fischer Scientific Inc. (Waltham, USA). Cells at 
passages 3-4 were used in all experiments. 
Discs were sterilized by immersion in 70% ethanol, and rinsed three times with Phosphate Buffered 
Saline (PBS, Gibco, Thermo Fisher Scientific Inc., Waltham, USA). Afterwards, samples were 
placed in 24-well plate and incubated with 2.5 ml medium/well overnight. 
 
2.3.2. Cell differentiation: Real-time quantitative PCR 
Cells were seeded on the samples (300 cells/mm2) and incubated for different time periods. The 
differentiation to osteoblastic phenotype was assessed by measuring gene expression of 
osteogenic markers (Table 2) by Real-Time quantitative Polymerase Chain Reaction (RT-qPCR). 
Total RNA was extracted at 6 h and 1 and 3 days using RNeasy Mini Kit (Qiagen GmbH, Hilden, 
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Germany), as recommended by the manufacturer. For osteocalcin (OCN), a late osteogenic 
marker, 7 and 14 days were also monitored. Prior to RNA extraction, samples were transferred into 
new well plate and they were rinsed with PBS (Gibco, Thermo Fisher Scientific Inc., Waltham, 
USA). Total RNA was quantified by NanoDrop ND-1000 spectrophotometer (NanoDrop Products, 
Thermo Fisher Scientific Inc., Waltham, USA) and 120 µg were used for synthesis of 
complementary DNA (cDNA) using the QuantiTect Reverse Transcription Kit (Qiagen GmbH, 
Hilden, Germany). cDNA templates were amplified using specific primers (Table 2) in SYBR Green 
RT-qPCR analyses using the QuantiTect SYBR Green RT-PCR Kit (Qiagen GmbH, Hilden, 
Germany) in an RT-PCR StepOnePlus (Applied Biosystems, Thermo Fisher Scientific Inc., 
Waltham, USA). The specificity of primers was ensured by melt curves analysis in all RT-qPCR 
runs. To verify the absence of contamination and genomic DNA, No-RNA control and No-RT 
enzyme control were evaluated in parallel. The expression of studied genes were normalised by 
expression of β-actin (housekeeping gene) and relative fold changes (FC) were related to tissue 
culture polystyrene (TCPS) at 6h of culture. The following formula were used: FC = Etarget
∆Cq target 
(TCPS 6h – sample) / Ehousekeeping
∆Cq housekeeping (TCPS 6 h – sample), where Cq is the median value of the 
quantification cycle of the triplicate of each sample and E corresponds to the efficiency of 
amplification and is determined from the slope of the log-linear portion of the calibration curve, as 
E=10
(-1/slope)
. The experiment was performed in two independent runs. 
 
 
Table 2. Primers’ sequences used for RT-qPCR 
Gene 
Gene 
symbol 
Forward primer sequence 
(5’ to 3’) 
Reverse primer sequence 
(5’ to 3’) 
β-actin ACTB CCCGCGAGTACAACCTTCT CGTCATCCATGGCGAACT 
Bone morphogenetic protein-2 BMP-2 CCCCTATATGCTCGACCTGT AAAGTTCCTCGATGGCTTCTT 
Alkaline phosphatase ALP GCACAACATCAAGGACATCG TCAGTTCTGTTCTTGGGGTACAT 
Collagen I Col I CATGTTCAGCTTTGTGGACCT GCAGCTGACTTCAGGGATGT 
Osteonectin ONN GTTTGAAGAAGGTGCAGAGGA GGTTCTGGCAGGGGTTTT 
Osteopontin OPN CGGTGAAAGTGGCTGAGTTT GGCTACAGCATCTGAGTGTTTG 
Osteocalcin OCN ATAGACTCCGGCGCTACCTC CCAGGGGATCTGGGTAGG 
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2.4 Statistical analysis  
The histomorphometric and in vitro results are presented as mean values ± standard error. 
Statistical comparisons between experimental groups were performed using One-way repeated 
measures ANOVA followed by Tukey’s post hoc test in GraphPad Prism software (GraphPad 
Software Inc., La Jolla, USA). A pair-wise comparison result of p<0.05 was considered statistically 
significant. 
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3. Results 
3.1. Materials characterization 
The textural properties of the different scaffolds including total porosity and macroporosity, 
determined by MIP and micro-CT, as well as, the BET specific surface area are summarized in 
Table 3. The architecture of the foamed and 3D-printed scaffolds, together with the microstructure 
of the different materials can be seen in the SEM images in Fig.1A and the pore size distribution, 
measured by MIP, is shown in Fig. 1B. Similar microstructures were observed for the CDHA-Foam, 
CDHA-Rob-450 and CDHA-Rob-250 with the typical entangled network of needle-like CDHA 
nanocrystals (Fig. 1A), which resulted in high SSA, around 35 g/m2 (Table 3). As a consequence, 
the three CDHA groups presented nanosized pores (Fig. 1B). However, whereas the robocast 
samples displayed a nanopore size distribution ranging from 0.006 to 0.1 µm, the CDHA-Foam 
group showed a wider and continuous distribution, covering both the nano and the microscale. In 
contrast, the two sintered ceramics (BCP-Foam and β-TCP-Foam) consisted of polyhedral crystals 
with smooth faces (Fig. 1A), displaying low SSA values (Table 3), an absence of nanoporosity and 
micropores centered around 1 µm for the β-TCP-Foam group and at 1.2 µm for the BCP-Foam 
group.  
All scaffolds presented similar amounts of macroposity and total porosity as shown in Table 3, 
although different pore sizes and, more markedly, different pore entrance sizes (Fig. 1, Table 3), 
larger for the robocast scaffolds. Moreover, as observed in Fig. 1A, the foamed scaffolds presented 
a very similar architecture with interconnected spherical macropores, irrespective of its biomimetic 
or sintered nature. 
Table 3. Porosity and SSA of the different scaffolds 
  Porosity  
Materials 
% Total 
Porosity by 
MIP 
% Macroporosity 
by MIP (>10 µm) 
% Macroporosity 
by micro-CT 
Macropore 
entrance size 
by MIP (µm)* 
Macropore size 
by micro-CT 
(µm)* 
SSA 
(m2/g) 
CDHA-Foam 76.5 49.5 52.3 70 227.0 38.49 
CDHA-Rob-450 64.8 46.5 47.4 350 409.7 32.02 
CDHA-Rob-250 65.4 48.7 54.1 200 288.7 32.35 
BCP-Foam 71.8 47.2 47.4 50 214.8 0.42 
β-TCP-Foam 64.6 43.2 48.9 40 232.0 0.46 
*Whereas by MIP provided the average entrance size of the macropores, the value measured by micro-CT corresponds 
to the average pore size itself.  
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Figure 1. A) Scanning electron micrographs of the five implanted materials: CDHA-Foam, BCP-Foam and β-TCP-Foam 
groups showed similar architecture, consisting of open and interconnected spherical concave macropores, while the 
robocast scaffolds presented open and interconnected prismatic convex macropores. The microstructure of the CDHA 
scaffolds consisted of the typical network of entangled needle-like nanocrystals, while the sintered ceramics showed 
polyhedral smooth crystals. B) Pore entrance size distribution of the five implanted materials as determined by MIP.  
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As shown by the XRD patterns (Supplementary Data, Fig. S2), the CDHA-Foam and the CDHA-
Rob scaffolds consisted of a poorly crystalline apatitic phase, as indicated by the broad peaks, 
typical of biomimetic apatites. Small amounts of unreacted α-TCP were detected, and quantified to 
be 2% and 3% for CDHA-Foam and CDHA-Rob scaffolds, respectively. The sintered scaffolds 
exhibited sharper peaks typical of highly crystalline materials. β-TCP-Foam scaffolds consisted of 
phase pure β-TCP and BCP-Foam consisted of a mixture of 82.7% HA and 17.3% β-TCP. 
 
 
3.2. Intramuscular implantation 
All surgeries were uneventful, all animals had a normal recovery after surgery and their 
postoperative course proceeded without any complications. No clinical evidence of inflammatory 
response or adverse tissue reaction around implants was observed during the experimental period 
or at retrieval. Histology showed low-grade peri-implant inflammatory reaction at both time points 
for all scaffolds, which were surrounded by well-vascularized muscle tissue. A small number of 
inflammatory cells, mainly limphoplasmocitary cells, were found and no fibrous capsule formation 
was observed, indicating the good biocompatibility of the different scaffolds. At 6 weeks fibrous 
tissue infiltration with abundant neovascularization was observed within the interconnected 
macropores, both in the foamed and the robocast scaffolds. Collagen fibres appeared to be 
oriented following the walls of the macropores (Fig. 2). 
 
Figure 2. Backscattered scanning electron micrographs (A,B) and micrographs of undecalcified Goldner-Masson 
trichrome stained sections (C,D) of a representative foam scaffold (A,C) and a robocast scaffold (B,D) after 6 weeks of 
implantation. All foams and robocast materials showed fibrous tissue infiltration and blood vessels (arrow heads) within 
the interconnected macropores at 6 weeks. M=Material, FT=Fibrous Tissue.  
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The results for new ectopic bone formation in the different scaffolds are summarized in Fig. 3. At 6 
weeks new bone was detected only in the CDHA-Foam group, in 4 out of 6 animals, while no signs 
of bone formation were found neither in the sintered ceramic foams nor in the biomimetic robocast 
scaffolds. In this group, although no statistically significant differences between the five concentric 
VOIs were noted, the ectopic bone was mainly found in the outer and middle regions 
(Supplementary Data, Fig. S3). No ectopic bone was observed on the outside surface of the 
cylinders. The newly formed bone was predominately located in the concavities of the macropores 
and in direct contact with the biomaterial, as shown in Fig. 4B, and consisted of a mineralized bone 
matrix, with osteocytes inside lacunae, and aligned osteoblasts laying down new osteoid (Fig.4D). 
The newly deposited bone was basically woven bone, with some areas of lamellar bone and a few 
Haversian structures (Fig. 4C). No endochondral ossification was detected during the ectopic bone 
formation process. 
 
 
Figure 3. A) Bone incidence after 6 and 12 weeks of implantation. B) Histomorphometrical results: % of newly formed 
bone within the available macropores space at 6 and 12 weeks post-implantation, as measured by μ-CT. The mean value 
for the CDHA-Rob-450 group was 0.01 ± 0.01%, hereby this is not appreciable in the graphic. (*) denotes groups with 
statistically significant differences (p < 0.05). C) Histomorphometrical results: % of newly formed bone within the available 
macropores space within the five volumes of interest (VOIs) after 12 weeks of implantation in CDHA-Foam and BCP-
Foam scaffolds. The bone was uniformly distributed over the entire implant in CDHA-Foams, whereas in BCP-Foams 
there was very little bone in the outer VOI and it was concentrated mostly in the middle VOIs.  (*) denotes groups with 
statistically significant differences (p < 0.05). 
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Figure 4. (A,B,C) Backscattered scanning electron micrographs of undecalcified section of a CDHA-Foam scaffold after 6 
weeks of implantation. B) The newly formed bone (white arrow heads) was arranged concentrically to the concave 
surface of scaffold macropores and always in direct contact with the material. Note the formation of well-mineralized bone 
matrix with some lacunae (white arrows). C) The new ectopic bone (white arrow heads) was basically woven bone with 
some osteon-like structures (white arrows). M=Material, ST=Soft tissue (in black). D) Micrograph of an undecalcified 
Goldner-Masson trichrome stained section of a CDHA-Foam scaffold after 6 weeks of implantation showing well-
mineralized bone matrix (in green), with osteocytes inside lacunae (white arrows), and aligned osteoblasts (black arrows) 
laying down new osteoid (in pink). M=Material. 
 
 
At 12 weeks, a significant amount of new ectopic bone was observed within the macropores of the 
CDHA-Foam group, in 6 out of 6 animals (27.98 ± 4.80% ectopic bone), as well as in the BCP-
Foam group, in 4 out of 6 animals (28.30 ± 10.11% ectopic bone) (Fig. 3B.). The bone was 
uniformly distributed over the entire implant in CDHA-Foams with no significant differences 
between the five concentric VOIs at this time point (Fig. 3C and Fig. 5A). However, BCP-Foams 
exhibited a repetitive pattern, with almost no bone formation in the outer VOI (VOI 5), and most 
bone concentrated in the middle VOI (VOI 3) (Fig. 3C and Fig. 5B). Moreover, distinctive bone 
formation patterns were observed in these two groups, as shown in Fig. 5. Whereas in the BCP-
Foam group the new bone was deposited on top of the surface of the scaffold, filling the macropore 
space (Fig. 5B), in the CDHA-Foam group the bone seemed to replace the scaffold (Fig. 5A).This 
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observation was confirmed when comparing the amount of pore volume before and after 
implantation in these two groups. Thus, even if both groups showed a similar amount of new 
ectopic bone formation, the fraction of total pore volume at 12 weeks decreased with 4.56% in the 
BCP-Foam group while it increased with 4.77% in the CDHA-Foam group when compared to the 
original scaffolds. The new ectopic bone was observed within macropores from 10 to 300 µm in 
diameter in both groups and it consisted in mature lamellar bone with some areas of osteonal bone 
following a Haversian pattern (Fig. 5A/5B and Fig. 6A/6B/6D/6E). Moreover, abundant extracellular 
calcified bone matrix was observed within the micropores (<10 µm) of these two groups as shown 
in Fig. 6G/6H. 
New ectopic bone was found just in 1 animal out of 6 in the CDHA-Rob-450 and β-TCP-Foam 
groups, in a small amount in both cases (Fig. 3A/3B and Fig. 5C/5D). In CDHA-Rob-450 bone was 
mostly found in the corners, which is the only part of robocast samples with concavities (Fig. 5D 
and Fig. 6C/6F). CDHA-Rob-250 scaffolds did not show any ectopic bone formation at 12 weeks 
(Fig. 3A/4B and Supplementary Data, Fig.S4). 
Some multinucleated osteoclast-like cells were consistently observed resorbing the materials in all 
scaffolds. However, a qualitative histological assessment identified a greater number of osteoclast-
like cells in the CDHA-Foam and BCP-Foam scaffolds (Fig. 6I/6J, respectively) than in the CDHA-
Rob and β-TCP-Foam samples at both time points.   
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Figure 5. Backscattered scanning electron micrographs after 12 weeks of implantation of studied scaffolds:  
A) CDHA-Foam. B) BCP-Foam. C) β-TCP-Foam. D) CDHA-Rob-450 robocast scaffold.  
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Figure 6. (A,B,C) Micrographs of undecalcified Goldner-Masson trichrome stained sections of CDHA-Foam, BCP-Foam 
and CDHA-Rob-450 scaffolds after 12 weeks of implantation showing well-mineralized bone matrix (in green), with 
osteocytes inside lacunae (white arrows), and aligned osteoblasts (black arrows) laying down new osteoid (pink). 
M=Material, Asterisk=blood vessel. (D,E,F) Micrographs of undecalcified Toludine blue stained sections of CDHA-Foam, 
BCP-Foam and CDHA-Rob-450 scaffolds after 12 weeks of implantation showing well-mineralized bone matrix (in 
purple), with osteocytes inside lacunae (black arrows) with bone canaliculi. In the CDHA-Rob-450, bone was mostly 
found in the corners, which is the only part of robocast samples with concave-like regions. M=Material, Asterisk=blood 
vessel. (G,H) Backscattered scanning electron micrographs of CDHA-Foam and BCP-Foam scaffolds after 12 weeks of 
implantation showing calcified bone matrix (asterisk) within micropores, next to an osteocyte (white arrow) located within 
a macropore. M=Material. (I,J,K) Micrographs of undecalcified Toluidine blue stained sections of CDHA-Foam, BCP-
Foam and CDHA-Rob-450 scaffolds after 12 weeks of implantation showing multinucleated osteoclast-like cells (black 
arrows) resorbing the material with intracellular scaffold particles. M=Material, Asterisk=Bone matrix.  
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The results concerning scaffold resorption of the different groups are summarized in Fig. 7A. A 
higher degradation was observed for the CDHA-Foam scaffolds compared to the other groups at 6 
weeks, whereas at 12 weeks CDHA-Foam and β-TCP-Foam showed a similar degradation, 
significantly higher than that of CDHA-Rob-450 and 250, and the BCP-Foam groups (Fig. 7A). 
Noteworthy, the degradation of the CDHA-Foam scaffolds was progressive and homogeneous, 
while that showed by the β-TCP-Foam scaffolds was more heterogeneous, leaving big holes within 
the constructs, as revealed by the micro-CT images (Fig. 7B). 
 
 
Figure 7. A) Histomorphometry results: % of scaffold degradation after 6 and 12 weeks of implantation. (*) denotes 
groups with statistically significant differences (p < 0.05). B) Micro-CT 3D reconstructions of implanted scaffolds after 12 
weeks of implantation.  
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3.3. In vitro study: cell differentiation (RT-qPCR) 
The expression profile of osteogenic markers of rMSCs was analysed in planar discs of the 
different materials used to fabricate the scaffolds, namely CDHA, BCP and β-TCP. The 
physicochemical properties of the discs are summarized in the Supplementary Data (Fig. S5). The 
results obtained by RT-qPCR analysis are displayed in Fig.8. The expression of BMP-2, OPN and 
OCN was significantly higher for cells cultured on CDHA compared to the sintered ceramics at all 
time-points, except for OCN at 6h. ALP, Col I and ONN expression followed similar trends, 
presenting the highest values at 6h and decreasing over time. Specifically, the expression of ALP 
for cells cultured on CDHA was significantly higher than on sintered ceramics at 6 h, while β-TCP 
showed significantly higher levels at 3 days compared to CDHA and BCP. Col I gene expression 
was significantly higher for cells cultured on CDHA compared to BCP at day 1. The expression of 
ONN by cells cultured on CDHA was significantly higher than on β-TCP at 6h and significantly 
higher than on the two sintered ceramics at day 1. Finally, for OCN, a late osteogenic marker, the 
analysis was prolonged until 7 and 14 days, finding a higher overexpression of OCN when cells 
were cultured on CDHA compared to the sintered ceramics at 7 days, whereas at 14 days similar 
values were found on CDHA and BCP, both higher than on β-TCP. 
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Figure 8. Gene expression of osteogenic markers of rMSCs cultured on planar discs of the different materials used to 
fabricate the scaffolds (CDHA, BCP and β-TCP) and measured by RT-qPCR. TCPS was used as a reference. Cells were 
cultured in basic medium. Statistical comparisons were performed between CaP materials. (*) denotes groups with 
statistically significant differences (p < 0.05). 
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4. Discussion 
The main goal of the present study was to obtain a better understanding of the role of textural 
properties and macropore architecture in osteoinduction, with the aim to shed light on the behaviour 
of biomimetic nanostructured materials compared to conventional sintered ceramics. Previous 
results pointed to microporosity and SSA as critical factors for the material-associated 
osteoinduction, although only a limited range of porosities and SSA had been analysed up to this 
moment. In this work, we have been able to extend this range to the nanoscale porosity, in 
combination with different macropore arquitectures. The results showed that both parameters are 
relevant, as foams induced ectopic bone formation to a much higher extent than robocast scaffolds, 
and amongst them, biomimetic nanostructured CDHA produced a higher incidence and accelerated 
bone formation when compared to microstructured sintered calcium phosphates. Moreover, 
different patterns of bone formation were observed, as will be discussed below. 
 
4.1 Animal model and surgical protocol 
The intrinsic osteoinductive potential of a biomaterial, e.g., its capacity to trigger the differentiation 
of mesenchymal stem cells to the osteoblastic lineage, can be proved by its ability to stimulate new 
bone formation when implanted ectopically in a host animal. In the present study the intramuscular 
implantation in a canine model was chosen, as ectopic bone formation is a species-dependent 
phenomenon, being more frequent in large (dog, sheep and goat) than in small animals (mouse, rat 
and rabbit)23-26. The higher vascularization of muscle compared to subcutaneous tissue was the 
reason for choosing this implantation site24,26.  
 
Concerning the surgical protocol, it is worth mentioning that in our study a non-steroidal anti-
inflammatory drug (NSAIDs) was administered to the animals post-operatively. This was done both 
for ethical reasons and in an attempt to be close to a real clinical situation, where NSAIDs, 
combined with opioid drugs, are routinely used for 7 to 10 days after orthopaedic surgeries to 
control pain and inflammation. This is relevant because it is well known that NSAIDS inhibit 
cyclooxygenase-2 function, impairing bone formation at early stages27. Moreover, it has been 
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suggested that a certain degree of inflammation might foster osteoinduction, through the local 
release of inflammatory cytokines, produced by monocytes and macrophages, which may stimulate 
circulating stem cells to differentiate into the osteoblastic lineage28-31. For this reason, most studies 
on biomaterial-associated osteoinduction just used opioid drugs post-operatively12,13,26,32,33 or no 
pain-reliever/analgesic drugs9,11,34-38. 
 
Interestingly, the use of NSAIDs did not impair nor reduce the incidence of ectopic bone formation 
compared to other studies. Although it is difficult to make direct comparisons due to the various 
animal models and different characteristics of the materials (granules, cement pastes, blocks, etc.) 
we found similar or even larger amounts of ectopic bone than in previous studies with analogous 
designs (intramuscular implantation in large species) 9,11,12,23,26,32-34,36,38-42. 
 
4.2 Effect of macropore geometry on osteoinduction 
The presence of interconnected macropores is considered to be a prerequisite for osteoinduction 
by biomaterials1,12,35,43. This is associated to the need of body fluid flow and vascular infiltration, 
with the corresponding oxygen and nutrient supply, and the easy access of cells (inflammatory 
cells, stem cells) and soluble proteins, including signaling molecules and osteogenic growth 
factors1,11.  
 
However, the results obtained in this work show that the presence of interconnected macroporosity 
is a necessary but not sufficient requirement. The shape of the macropores seems to be critical for 
osteoinduction. Three groups of CDHA scaffolds with the same chemical composition, similar 
percentage of interconnected macroporosity and similar nanostructure and SSA, but different 
macropore architecture were analysed. It was decided to keep constant the total porosity between 
the foamed and robocast scaffolds, and this resulted in different pore entrance sizes (Table 3). 
CDHA-Foam exhibited concave macropores with bottle-neck morphology, pore diameters between 
10 and 300 µm and pore entrance sizes around 70 µm. In contrast, the robocast scaffolds 
presented prismatic convex macropores with pore dimensions around 350 µm for CDHA-Rob-450 
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and 200 µm for CDHA-Rob-250 (Fig. 1 and Table 3). Whereas ectopic bone was formed in the 
CDHA-Foam in 4 out of 6 animals at 6 weeks and in all animals at 12 weeks, in the CDHA-Rob-450 
group, bone was formed just in 1 out of 6 animals at 12 weeks, in a very small amount, and no 
signs of bone formation were observed in the CDHA-Rob-250 at both time points (Fig. 3A/3B). 
Remarkably, ectopic bone in the CDHA-Rob-450 group was found only in the corners, where 
robocast scaffolds show concave-like regions (Fig. 5D and Fig. 6C/6F). It is worth mentioning that 
no correlation was found between angiogenesis and ectopic bone formation, since abundant 
neovascularization, homogenously distributed throughout the constructs, was observed both in the 
foams and in the robocast scaffolds (Fig. 2).  
 
Although most authors recognize the positive effect of concave porosity on osteoinduction12,43, 
there is still controversy. Wang et al.41 reported a better osteoinductive potential for HA-based 
biomaterials with channel-like architectures with convex surfaces compared to scaffolds with 
honeycomb-like architectures with concave surfaces. However, in our case the results pointed quite 
categorically to the need of concave macropores to trigger osteoinduction. This suggests that the 
spherical macropores provided confined spaces, which acted as niches with the adequate 
microenvironment for the differentiation of MSCs to osteoblasts. This includes, on one side the 
concentration of calcium and phosphate at the vicinity of the scaffold, and on the other the 
presence and retention of osteoinductive growth factors. This microenvironment would not be 
preserved in the more open structure of the robocast scaffolds, where both ions and proteins would 
easily diffuse instead of being retained locally. 
 
Moreover, recent studies have shown that, in addition to triggering osteoinduction, geometry is a 
factor that contributes to controlling the kinetics of tissue deposition by osteoblastic cells44-46. 
Specifically, these authors have demonstrated that bone matrix deposition by osteoblasts 
happened in concave surfaces rather than in convex or flat surfaces, and moreover, the local 
growth rate of tissue formed in concave spaces was proportional to the concave curvature, which is 
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in good agreement with the higher amount of bone found in the foamed scaffolds, and the 
localization of bone in the corners of the robocast scaffolds (Fig. 5D and Fig. 6C/6F). 
 
4.3 Effect of Micro/nanostructural parameters on osteoinduction 
Foamed scaffolds with similar percentage of spherical concave macroporosity but different 
chemical composition, microstructure and SSA were compared. The analysis of the micro-CT 
images, together with the BS-SEM images allowed to precisely calculating the volume of newly 
formed bone in each scaffold21. CDHA-Foam was the only group that showed ectopic bone 
formation at 6 weeks, while no signs of bone formation were observed in the sintered ceramics 
(BCP and β-TCP foams) at this time point. Moreover, it was the only group showing a significant 
amount of ectopic bone formation in all animals at 12 weeks, whilst at this time point, bone 
formation was observed only in 4 out of 6 animals in the BCP-Foam group and 1 out of 6 animals in 
the β-TCP-Foam group. 
 
These results point in the same direction as previous studies which clearly showed that the 
microstructure of CaP-based biomaterials plays a determining role in stimulating osteoinduction 2,10-
13,33,42,47-49. Several in vivo studies have evaluated CaP-based biomaterials with different 
microstructures, consistently showing the best results in terms of osteoinduction in the CaPs with 
higher levels of microporosity and higher SSA12,13,26,32,33,42,48,49. However, only sintered ceramics, 
which have the limitation of lacking nanoporosity, have been analysed in this respect so far. 
Although different strategies have been explored to overcome this limitation, such as reducing the 
sintering temperature 26,33,42, using spark plasma sintering to avoid grain coarsening50,51, or covering 
the surface of sintered ceramics with nano-hydroxyapatite coatings obtained by hydrothermal 
routes52, these strategies did not manage to increase substantially the SSA of the materials, 
reaching values only around 6-10 m2/g. In contrast, the biomimetic processing used in this work 
allowed obtaining foamed CDHA scaffolds exhibiting, in addition to the interconnected macropores, 
also porosity in the micro and the nanoscale, and a SSA as high as 38 m2/g. 
 
28 
 
The results obtained suggest that some mechanisms relevant for osteoinduction, such as the 
release of calcium and phosphate ions, in combination with the entrapment or attraction of relevant 
proteins and growth factors (e.g. BMPs)7,12 are promoted in nanostructured biomimetic materials. 
 
It is worth mentioning that poor results in terms of ectopic bone formation were obtained in previous 
studies with calcium phosphate cements, with similar composition to the CDHA used in the present 
work36,53. However, this could be attributed to the lack of interconnected macroporosity in the 
cement pastes and prehardened scaffolds. In contrast, the foaming and 3D-inkjet printing 
techniques used in the present study, allowed combining the required interconnected 
macroporosity and micro/nanoporosities relevant for the osteoinductive processes. 
 
Besides the acceleration and promotion of the process of osteoinduction, clear differences were 
observed in the pattern of bone formation, when comparing CDHA and BCP Foams (Fig. 5A/5B). 
Whereas bone was deposited on the surface of the scaffold in the BCP-Foam, resulting in the 
progressive filling of the macropores, in the CDHA-Foam bone replaced the pre-existing scaffold 
structure, meaning that bone formation was preceded by the resorption of the scaffold. This trend 
was confirmed by the higher degradation rate measured for the CDHA-Foams (Fig. 7), as will be 
discussed below.     
 
To better understand the role that nanostructure and phase composition played in the differentiation 
of MSC, rMSC were cultured without adding osteogenic factors, on the surface of discs of the 
different materials used in the in vivo study. An overexpression of some osteogenic genes, namely 
BMP-2, ONN, OPN, OCN was found more pronounced on CDHA discs than in the sintered BCP 
and β-TCP groups, indicating that biomimetic CDHA triggered the osteogenic differentiation of 
rMSCs (Fig. 8). The calcium and phosphate fluctuations registered in the cell culture medium in 
contact with the different materials during the cell culture study were not statistically significant 
(Supplementary Data, Fig. S5E). Therefore, the osteogenic differentiation produced was mostly 
attributed to the topographical features, which have been identified as a parameter controlling 
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differentiation of mesenchymal stem cells54,55. This, in fact, is in agreement with previous studies 
where osteogenic differentiation of rMSC cultured on CDHA or in other nanostructured substrates 
like octacalcium phosphate was observed56,57. Similarly, other authors reported higher osteogenic 
differentiation of MSCs on low-temperature nanocrystalline HA compared to sintered HA, 
suggesting that nanoporosity, surface roughness and nanocrystal morphology are responsible for 
osteoinduction of MSCs58,59.  
 
In this study, besides the bone formed within concave macropores from 10 to 300 µm of diameter in 
CDHA-Foam and BCP-Foam (Fig. 6A/6B), abundant extracellular calcified bone matrix was 
observed within the micropores (<10 µm) of both groups (Fig. 6G/6H). Other authors have 
previously reported the presence of calcified bone matrix within micropores. In some cases it has 
been associated with the osteoid produced by nearby cells being able to flow and penetrate into 
small micropores49,60,61. In contrast, other authors claim that this calcified tissue might be produced 
by the invasion of the micropores by bone cells62,63, through pore-interconnections smaller than 
their diameter (4-12 µm)64. Although in our case no cells were seen within the micropores, immuno-
histochemical staining using for example an osteocyte marker like sclerostin63 would be needed to 
conclusively exclude the presence of cells. Unfortunately, this was not possible since the samples 
were embedded in resin, which did not allow this type of immuno-histochemical investigation.    
 
Regarding spatial distribution, bone was found only inside the foamed constructs, but not on the 
external surface of the cylinders. As displayed in Fig. 5A, bone was uniformly distributed within the 
CDHA-Foam scaffolds with no significant differences between the five concentric VOIs (Fig. 3C). 
However, BCP-Foams consistently showed minimal bone formation in the outer VOI (VOI 5) and 
most of the new bone concentrated in the middle VOI (VOI 3) (Fig. 3C and Fig. 5B). This pattern for 
the BCP-Foams agrees with previous studies where bone induction was observed only in the 
centre of the implant and not in the implant periphery. This was attributed, on one side, to the fast 
diffusion of the released calcium and phosphate ions at the peripheral regions of the scaffolds, 
which prevented reaching the supersaturation required for ectopic bone formation and on the other 
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side, to the shear stresses on the outer regions of the ceramic blocks that might prevent bone 
tissue formation12. However, in the case of CDHA-Foams, the presence of bone uniformly 
distributed within the entire construct, including the periphery, can be explained by the higher 
reactivity of the substrate, associated both with chemical composition and textural properties, which 
led to higher implant degradation, resulting in higher levels of calcium and phosphate release in the 
whole volume of the construct.  
 
4.4 Degradation patterns and osteoinduction 
The role of CaP degradation in osteoinduction is still unknown. Some authors claim that, whereas 
certain degree of degradation is desirable, since it provides the calcium and phosphate ions 
needed to stimulate MSC differentiation and foster mineralization, a too high degradation may 
impair osteoinduction due to the lack of a stable surface where the new bone can be deposited7. 
This is the argument used to explain the higher osteoinduction found in BCP ceramics compared to 
both the hardly soluble sintered stoichiometric HA and the more soluble β-TCP12,26,32,35,37,47. The 
analysis of the micro-CT data obtained in this work allowed quantifying in 3D the resorption of the 
different scaffolds, showing different patterns when looking at sintered ceramics or at biomimetic 
CDHA. 
 
When comparing the foamed scaffolds, the results showed that the material presenting the highest 
osteoinduction, CDHA-Foam, was the one showing also the highest degradation, above that of 
sintered foams (BCP and β-TCP) at 6 weeks, and above the BCP-Foam, but similar to the β-TCP-
Foam at 12 weeks (Fig. 7). The high degradation rate of CDHA, compared particularly to the more 
soluble β-TCP, agrees with previous studies65 and can be explained by its specific features, i.e., the 
nanosized crystals and consequently high SSA, as well as its low crystallinity and lack of 
stoichiometry. The degradation of the BCP-Foam, which presented a high amount of ectopic bone 
formation at 12 weeks, was significantly smaller. This can be associated to the low solubility of 
sintered HA, together with the low SSA, and can be the reason for the delayed ectopic bone 
formation compared to the CDHA-Foam. In the BCP-Foam, a longer time was probably required to 
31 
 
achieve the supersaturation of the local environment with calcium and phosphate ions, which 
precedes new ectopic bone formation. On the other hand, the bone formation pattern described in 
the previous section is in good agreement with this lower degradation of the BCP-Foam, as bone 
was deposited on the surface of the scaffold instead of replacing the biomaterial (Fig. 5). 
 
The results obtained demonstrate that the high resorption rate of CDHA-Foam, far from being an 
obstacle for osteoinduction, clearly promoted it. Considering that the physiological fluid is 
supersaturated with respect to CDHA, the homogeneous and progressive degradation of the 
CDHA-Foam scaffolds suggested that the high degradation profile of the CDHA-Foam scaffolds 
was mainly due to the multinucleated osteoclast-like cells activity (Fig. 6G), as also reported by 
Yuan et al.36. These results are in good agreement with previous studies, which emphasized the 
promotion of osteoclastic activity by submicrometric microstructures of CaP, and its close relation 
with osteoinduction13,25,33,48,66. The secretion of BMPs and other osteogenic growth factors by 
osteoclasts are able to trigger MSCs differentiation toward the osteogenic lineage, this leading 
eventually to bone formation through intramembranous ossification7,34,66-69, as observed in the 
present study. It is noteworthy, however, that previous studies reported a lack of osteoinductive 
properties of carbonated hydroxyapatites with a SSA between 7 and 10 m2/g26,70. Therefore, it was 
hypothesized that there was a limit in the increase of SSA of biomaterials that positively influences 
osteoinduction, adducing that materials with a SSA above the optimum might degrade too fast26. In 
contrast, the present results demonstrate that it is possible to couple degradation and bone 
formation in an ectopic site. 
 
The situation with the β-TCP foams was different. Although the degradation percentage at 12 
weeks was similar to CDHA foams, the degradation pattern was very heterogeneous, leaving big 
holes within the constructs (Fig. 7B). The loss of a stable three-dimensional macrostructure, which 
is required to facilitate new bone growth was probably the main reason why this group did not show 
a significant ectopic bone formation (Fig. 4A/4B), despite having the same macroporosity, 
microstructure and SSA as the BCP-Foam group (Fig. 1 and Table 2). 
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Remarkably, pore architecture also had a significant effect on the degradation of the scaffolds. 
CDHA-Foam scaffolds showed a higher degradation than the biomimetic robocast scaffolds at both 
time points (Fig. 8), in spite of having identical chemical composition, and very similar 
nanostructure and SSA, which should entail similar dissolution rates. Noteworthy, a higher number 
of osteoclast-like cells were identified in the concave macropores of the CDHA-Foam, compared to 
the convex prismatic macropores of the robocast scaffolds. These findings suggested that 
osteoclast-like cells activity, and consequently cell-mediated degradation, were enhanced by the 
microenvironment created inside the concave macropores. Likewise, the lack of osteoinduction by 
the robocast scaffolds confirms in turn the close relation between osteoclastic activity and 
osteoinduction.   
 
Overall, besides providing additional information about the role of structural parameters in 
osteoinduction and the biological mechanisms behind it, the enhanced osteoinduction of the 
biomimetic CDHA-Foams has a direct clinical application for the repair of large bone defects. Some 
studies have demonstrated the clinical utility of osteoinductive bone substitutes for the treatment of 
critical sized bone defects, showing that these materials are better bone void fillers than those that 
are merely osteoconductive8,9,37,70. Thus, the next step will be to confirm this hypothesis evaluating 
these novel biomimetic CaP scaffolds in an orthotopic model. 
 
5. Conclusions 
The results obtained in this study show that both pore architecture and reactivity of the substrate 
play a crucial role in osteoinduction. The high reactivity of biomimetic CDHA, which results from its 
poor crystallinity, nanostructured nature and high SSA, combined with the concave macroporosity 
produced by a foaming process, resulted in an accelerated osteoinduction, when compared to 
conventional sintered BCP ceramics with the same macropore architecture. Different bone 
formation patterns were exhibited by sintered and biomimetic scaffolds. Whereas CDHA scaffolds 
were progressively resorbed and replaced by new ectopic bone, in the BCP scaffolds bone was 
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deposited on the surface of the material, progressively filling the pore space. Conversely, very 
limited osteoinduction was found in the 3D robocast scaffolds with prismatic pore geometries. In 
conclusion, we have shown that tailoring both nanostructure and macropore geometry of 
biomimetic CDHA obtained by a low-temperature self-setting reaction allows pushing the 
osteoinduction potential beyond the limits obtained for the microstructured calcium phosphate 
ceramics. 
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